These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1138 related items for PubMed ID: 19695405
1. Bioequivalence of generic and branded subcutaneous enoxaparin: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male subjects. Feng L, Shen-Tu J, Liu J, Chen J, Wu L, Huang M. Clin Ther; 2009 Jul; 31(7):1559-67. PubMed ID: 19695405 [Abstract] [Full Text] [Related]
2. Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: a randomized sequence, open-label, two-way crossover study. Chen L, Jiang X, Huang L, Lan K, Wang H, Hu L, Ren J, Li X, Zou Q. Clin Ther; 2009 Oct; 31(10):2242-8. PubMed ID: 19922895 [Abstract] [Full Text] [Related]
3. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers. Iqbal M, Khuroo A, Batolar LS, Tandon M, Monif T, Sharma PL. Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995 [Abstract] [Full Text] [Related]
4. Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin A microemulsion: a randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers. Piñeyro-López A, Piñeyro-Garza E, Torres-Alanís O, Reyes-Araiza R, Gómez-Silva M, Waksman N, E Salazar-Leal M, Luján-Rangel R. Clin Ther; 2007 Sep; 29(9):2049-54. PubMed ID: 18035203 [Abstract] [Full Text] [Related]
5. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M. Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [Abstract] [Full Text] [Related]
6. Biomarkers and coagulation tests for assessing the biosimilarity of a generic low-molecular-weight heparin: results of a study in healthy subjects with enoxaparin. Kuczka K, Harder S, Picard-Willems B, Warnke A, Donath F, Bianchini P, Parma B, Blume H. J Clin Pharmacol; 2008 Oct; 48(10):1189-96. PubMed ID: 18716314 [Abstract] [Full Text] [Related]
7. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S. Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [Abstract] [Full Text] [Related]
8. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers. Galan-Herrera JF, Poo JL, Rosales-Sanchez O, Fuentes-Fuentes E, Cariño L, Burke-Fraga V, Namur S, Parra MG. Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138 [Abstract] [Full Text] [Related]
9. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers. Boonleang J, Panrat K, Tantana C, Krittathanmakul S, Jintapakorn W. Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293 [Abstract] [Full Text] [Related]
10. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions. Spínola AC, Almeida S, Filipe A, Neves R, Trabelsi F, Farré A. Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489 [Abstract] [Full Text] [Related]
11. Relative bioavailability of two oral formulations of piroxicam 20 mg: a single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Mexican adult volunteers. Palma-Aguirre JA, Lopez-Gamboa M, Cariño L, Burke-Fraga V, González-de la Parra M. Clin Ther; 2010 Feb; 32(2):357-64. PubMed ID: 20206793 [Abstract] [Full Text] [Related]
12. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers. Rhim SY, Park JH, Park YS, Lee MH, Kim DS, Shaw LM, Yang SC, Kang JS. Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104 [Abstract] [Full Text] [Related]
13. Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers. Parrillo-Campiglia S, Ercoli MC, Umpierrez O, Rodríguez P, Márquez S, Guarneri C, Estevez-Parrillo FT, Laurenz M, Estevez-Carrizo FE. Clin Ther; 2009 Oct; 31(10):2224-32. PubMed ID: 19922893 [Abstract] [Full Text] [Related]
14. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers. Piñeyro-López A, Pineyro-Garza E, Torres-Alanís O, Reyes-Araiza R, Gómez Silva M, Wacksman N, Lujàn Rangel R, de Lago A, Trejo D, Gonzàlez-de la Parra M, Namur S. Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584 [Abstract] [Full Text] [Related]
15. Relative bioavailability of generic and branded 250-mg and 500-mg oral chlorphenesin carbamate tablets in healthy Korean volunteers: a single-dose, randomized-sequence, open-label, two-period crossover trial. Yu JY, Song HH, Kim BG, Park HJ, Choi KS, Kwon YE. Clin Ther; 2009 Nov; 31(11):2735-43. PubMed ID: 20110015 [Abstract] [Full Text] [Related]
16. Bioequivalence of single 100-mg doses of two oral formulations of topiramate: an open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers. Piñeyro-López A, Piñeyro-Garza E, Gómez-Silva M, Reyes-Araiza R, Flores-Diego MA, Borrego-Alvarado S, Gamino-Peña ME, Vargas-Zapata R, Salazar-Leal ME. Clin Ther; 2009 Feb; 31(2):411-7. PubMed ID: 19302913 [Abstract] [Full Text] [Related]
17. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA. Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [Abstract] [Full Text] [Related]
18. Bioequivalence evaluation of single doses of two tramadol formulations: a randomized, open-label, two-period crossover study in healthy Brazilian volunteers. Silva Mde F, Schramm SG, Kano EK, Mori Koono EE, Porta V, dos Reis Serra CH. Clin Ther; 2010 Apr; 32(4):758-65. PubMed ID: 20435245 [Abstract] [Full Text] [Related]
19. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers. Ahmad M, Pervaiz F. Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997 [Abstract] [Full Text] [Related]
20. Bioequivalence of two tablet formulations of clopidogrel in healthy Argentinian volunteers: a single-dose, randomized-sequence, open-label crossover study. Di Girolamo G, Czerniuk P, Bertuola R, Keller GA. Clin Ther; 2010 Jan; 32(1):161-70. PubMed ID: 20171421 [Abstract] [Full Text] [Related] Page: [Next] [New Search]